The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | M | Musculo-skeletal system | |
| 2 | M01 | Antiinflammatory and antirheumatic products | |
| 3 | M01A | Antiinflammatory and antirheumatic products, non-steroids | |
| 4 | M01AC | Oxicams | |
| 5 | M01AC06 | Meloxicam |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| ORAL - Oral | 15 mg |
| PAREN - Parenteral | 15 mg |
| RECTAL - Rectal | 15 mg |
| Active Ingredient | Description | |
|---|---|---|
| Meloxicam |
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam family, with anti-inflammatory, analgesic and antipyretic properties. The anti-inflammatory activity of meloxicam has been proven in classical models of inflammation. As with other NSAID, its precise mechanism of action remains unknown. However, there is at least one common mode of action shared by all NSAID (including meloxicam): inhibition of the biosynthesis of prostaglandins, known inflammation mediators. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| FLAMARYX Tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| MELCAM Tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| MELOREX Tablet | Medicines and Medical Devices Safety Authority (NZ) | MPI, EU: SmPC | |
| MELOX Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| MELOXICAM Orodispersible tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| MOBIC Tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| MOXICAM Tablet | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
